LOCKHART STEPHEN 4
4 · Emergent BioSolutions Inc. · Filed Nov 16, 2010
Insider Transaction Report
Form 4
LOCKHART STEPHEN
SVP, Product Development
Transactions
- Exercise/Conversion
Common Stock
2010-11-11$10.68/sh+11,667$124,604→ 35,313 total - Exercise/Conversion
Employee Stock Option (right to buy)
2010-11-11−16,666→ 0 totalExercise: $10.38Exp: 2014-10-19→ Common Stock (16,666 underlying) - Exercise/Conversion
Common Stock
2010-11-11$10.38/sh+16,666$172,993→ 23,646 total - Sale
Common Stock
2010-11-11$18.66/sh−28,333$528,694→ 6,980 total - Exercise/Conversion
Employee Stock Option (right to buy)
2010-11-11−11,667→ 5,833 totalExercise: $10.68Exp: 2015-08-11→ Common Stock (11,667 underlying)
Footnotes (2)
- [F1]The option vested in three equal installments on October 19, 2008, 2009, and 2010.
- [F2]The option vested in two equal installments on August 11, 2009, and 2010; the remainder will vest on August 11, 2011.